BMP2 and prostate carcinoma: In long-term experiments, prostate cancer cells exposed to BMP-2 concentrations attainable in vitro (50-100 ng/ml) from endothelial cells exposed to 5 μM 4HPR, showed a slight but significant decreased proliferation and reduced chemotactic and invasive activities.